Enzyme-Linked Immunosorbent Assay (ELISA) Technologies Market Report
RA01389
Enzyme-Linked Immunosorbent Assay (ELISA) Technologies Market , by Application (Immunology, Inflammation, Infectious diseases, Cancer, Protein quantitation, Other), Test Type (Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, Competitive ELISA): Global Opportunity Analysis and Industry Forecast, 2020-2027
The research report offers a comprehensive analysis of the global enzyme-linked immunosorbent assay (elisa) technologies market
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Enzyme-Linked Immunosorbent Assay (ELISA) Technologies Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Enzyme-Linked Immunosorbent Assay (ELISA) Technologies Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Enzyme-Linked Immunosorbent Assay (ELISA) Technologies Market , By Technology
5.1. Overview
5.2 Immunology
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Inflammation
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Infectious diseases
5.4.1 Definition, key trends, growth factors, and opportunities
5.4.2 Market size analysis, by region, 2020-2027
5.4.3 Market share analysis, by country, 2020-2027
5.5 Cancer
5.5.1 Definition, key trends, growth factors, and opportunities
5.5.2 Market size analysis, by region, 2020-2027
5.5.3 Market share analysis, by country, 2020-2027
5.6 Protein quantitation
5.6.1 Definition, key trends, growth factors, and opportunities
5.6.2 Market size analysis, by region, 2020-2027
5.6.3 Market share analysis, by country, 2020-2027
5.7 Other
5.7.1 Definition, key trends, growth factors, and opportunities
5.7.2 Market size analysis, by region, 2020-2027
5.7.3 Market share analysis, by country, 2020-2027
5.8 Research Dive Exclusive Insights
5.8.1 Market attractiveness
5.8.2 Competition heatmap
-
6. Enzyme-Linked Immunosorbent Assay (ELISA) Technologies Market , By Disease Pathology
6.1. Overview
6.2 Sandwich ELISA
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Indirect ELISA
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Multiple and portable ELISA
6.4.1 Definition, key trends, growth factors, and opportunities
6.4.2 Market size analysis, by region, 2020-2027
6.4.3 Market share analysis, by country, 2020-2027
6.5 Competitive ELISA
6.5.1 Definition, key trends, growth factors, and opportunities
6.5.2 Market size analysis, by region, 2020-2027
6.5.3 Market share analysis, by country, 2020-2027
6.6 Research Dive Exclusive Insights
6.6.1 Market attractiveness
6.6.2 Competition heatmap
7. Enzyme-Linked Immunosorbent Assay (ELISA) Technologies Market , By Region
7.1 North America
7.1.1 U.S
7.1.1.1 Market size analysis, By Technology, 2020-2027
7.1.1.2 Market size analysis, By Disease Pathology, 2020-2027
7.1.2 Canada
7.1.2.1 Market size analysis, By Technology, 2020-2027
7.1.2.2 Market size analysis, By Disease Pathology, 2020-2027
7.1.3 Mexico
7.1.3.1 Market size analysis, By Technology, 2020-2027
7.1.3.2 Market size analysis, By Disease Pathology, 2020-2027
7.1.4 Research Dive Exclusive Insights
7.1.4.1 Market attractiveness
7.1.4.2 Competition heatmap
7.2 Europe
7.2.1 Germany
7.2.1.1 Market size analysis, By Technology, 2020-2027
7.2.1.2 Market size analysis, By Disease Pathology, 2020-2027
7.2.2 UK
7.2.2.1 Market size analysis, By Technology, 2020-2027
7.2.2.2 Market size analysis, By Disease Pathology, 2020-2027
7.2.3 France
7.2.3.1 Market size analysis, By Technology, 2020-2027
7.2.3.2 Market size analysis, By Disease Pathology, 2020-2027
7.2.4 Spain
7.2.4.1 Market size analysis, By Technology, 2020-2027
7.2.4.2 Market size analysis, By Disease Pathology, 2020-2027
7.2.5 Italy
7.2.5.1 Market size analysis, By Technology, 2020-2027
7.2.5.2 Market size analysis, By Disease Pathology, 2020-2027
7.2.6 Rest of Europe
7.2.6.1 Market size analysis, By Technology, 2020-2027
7.2.6.2 Market size analysis, By Disease Pathology, 2020-2027
7.2.7 Research Dive Exclusive Insights
7.2.7.1 Market attractiveness
7.2.7.2 Competition heatmap
7.3 Asia-Pacific
7.3.1 China
7.3.1.1 Market size analysis, By Technology, 2020-2027
7.3.1.2 Market size analysis, By Disease Pathology, 2020-2027
7.3.2 Japan
7.3.2.1 Market size analysis, By Technology, 2020-2027
7.3.2.2 Market size analysis, By Disease Pathology, 2020-2027
7.3.3 India
7.3.3.1 Market size analysis, By Technology, 2020-2027
7.3.3.2 Market size analysis, By Disease Pathology, 2020-2027
7.3.4 Australia
7.3.4.1 Market size analysis, By Technology, 2020-2027
7.3.4.2 Market size analysis, By Disease Pathology, 2020-2027
7.3.5 South Korea
7.3.5.1 Market size analysis, By Technology, 2020-2027
7.3.5.2 Market size analysis, By Disease Pathology, 2020-2027
7.3.6 Rest of Asia-Pacific
7.3.6.1 Market size analysis, By Technology, 2020-2027
7.3.6.2 Market size analysis, By Disease Pathology, 2020-2027
7.3.7 Research Dive Exclusive Insights
7.3.7.1 Market attractiveness
7.3.7.2 Competition heatmap
7.4 LAMEA
7.4.1 Brazil
7.4.1.1 Market size analysis, By Technology, 2020-2027
7.4.1.2 Market size analysis, By Disease Pathology, 2020-2027
7.4.2 Saudi Arabia
7.4.2.1 Market size analysis, By Technology, 2020-2027
7.4.2.2 Market size analysis, By Disease Pathology, 2020-2027
7.4.3 UAE
7.4.3.1 Market size analysis, By Technology, 2020-2027
7.4.3.2 Market size analysis, By Disease Pathology, 2020-2027
7.4.4 South Africa
7.4.4.1 Market size analysis, By Technology, 2020-2027
7.4.4.2 Market size analysis, By Disease Pathology, 2020-2027
7.4.5 Rest of LAMEA
7.4.5.1 Market size analysis, By Technology, 2020-2027
7.4.5.2 Market size analysis, By Disease Pathology, 2020-2027
7.4.6 Research Dive Exclusive Insights
7.4.6.1 Market attractiveness
7.4.6.2 Competition heatmap
8. Competitive Landscape
8.1 Top winning strategies, 2020-2027
8.1.1 By strategy
8.1.2 By year
8.2 Strategic overview
8.3 Market share analysis, 2020-2027
9. Company Profiles
9.1 Ortho-Clinical Diagnostics
9.1.1 Overview
9.1.2 Business segments
9.1.3 Product portfolio
9.1.4 Financial performance
9.1.5 Recent developments
9.1.6 SWOT analysis
9.2 Inc.
9.2.1 Overview
9.2.2 Business segments
9.2.3 Product portfolio
9.2.4 Financial performance
9.2.5 Recent developments
9.2.6 SWOT analysis
9.3 Thermo Fisher Scientific. Inc.
9.3.1 Overview
9.3.2 Business segments
9.3.3 Product portfolio
9.3.4 Financial performance
9.3.5 Recent developments
9.3.6 SWOT analysis
9.4 Life Technologies Corporation
9.4.1 Overview
9.4.2 Business segments
9.4.3 Product portfolio
9.4.4 Financial performance
9.4.5 Recent developments
9.4.6 SWOT analysis
9.5 ZEUS Scientific
9.5.1 Overview
9.5.2 Business segments
9.5.3 Product portfolio
9.5.4 Financial performance
9.5.5 Recent developments
9.5.6 SWOT analysis
9.6 Inc.
9.6.1 Overview
9.6.2 Business segments
9.6.3 Product portfolio
9.6.4 Financial performance
9.6.5 Recent developments
9.6.6 SWOT analysis
Research Methodology
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com